Oragenics OGEN
NYSE OGEN
$0.49 -0.02 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oragenics (OGEN) Return on Capital Employed [ROCE] (2012 - 2023)

Updated

Oragenics (OGEN) posted Return on Capital Employed [ROCE] of -451.05% for Q4 2023, down 350.27 percentage points from -100.78% a year earlier and down 297.54 percentage points from the prior quarter.

Analysis

Oragenics (OGEN) Return on Capital Employed [ROCE] (2012 - 2023) Analysis & Trends

For FY2023, Oragenics' Return on Capital Employed [ROCE] came in at -259.24%, down 186.76 percentage points from FY2022.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -185.01 percentage points (FY2018 to FY2023).
  • In prior years, Oragenics' Return on Capital Employed [ROCE] was -72.47% in FY2022 (-0.82 pp), -71.65% in FY2021 (+77.40 pp), -149.05% in FY2020 (-65.70 pp) and -83.34% in FY2019 (-9.12 pp).
  • The Q4 2023 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q3 2015.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last seven quarters, with an average year-over-year change of -72.73 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2021, with a gain of 201.81 percentage points; the weakest was Q4 2023, with a drop of 350.27 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -153.51% (Q3 2023), -133.47% (Q2 2023) and -109.02% (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Oragenics 2.30 Mn 2.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -451.05%
Sep 30, 2023 -153.51%
Jun 30, 2023 -133.47%
Mar 31, 2023 -109.02%
Dec 31, 2022 -100.78%
Sep 30, 2022 -84.20%
Jun 30, 2022 -71.97%
Mar 31, 2022 -61.29%
Dec 31, 2021 -55.89%
Sep 30, 2021 -58.17%
Jun 30, 2021 -53.03%
Mar 31, 2021 -98.13%
Dec 31, 2020 -195.33%
Sep 30, 2020 -259.99%
Jun 30, 2020 -213.48%
Mar 31, 2020 -113.33%
Dec 31, 2019 -79.98%
Sep 30, 2019 -65.28%
Jun 30, 2019 -51.01%
Mar 31, 2019 -46.00%
API Access

Oragenics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OGEN&period=max&api_key=YOUR_API_KEY